Gibson Christopher
- SEC CIK
- 0001856369
In the past year, 16 open-market sale filings worth $3.37M and no purchases.
Current role at each company
- RXRX Recursion Pharmaceuticals, Inc.Directoras of Jun 5, 2026
- PACB Pacific Biosciences of California, Inc.Directoras of Jun 4, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $3.37M
- 16 filings
- Net
- −$3.37M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Gibson Christopher as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RXRX Recursion Pharmaceuticals, Inc.
Director104 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 (view filing) | Jun 5 | Same day | Gibson ChristopherDirector | SSaleClass A Common Stock | −40.0K | $3.62 | −$144.8K | −4.3%883.7K after | 10b5-1 |
| May 27, 2026 (view filing) | May 22 | 5 days | Gibson ChristopherDirector | SSaleClass A Common Stock | −40.0K | $3.08 | −$123.2K | −4.3%883.7K after | 10b5-1 |
| May 8, 2026 (view filing) | May 7 | 1 day | Gibson ChristopherDirector | SSaleClass A Common Stock | −40.0K | $3.37 | −$134.8K | −4.1%926.6K after | 10b5-1 |
| Apr 24, 2026 (view filing) | Apr 22 | 2 days | Gibson ChristopherDirector | SSaleClass A Common Stock | −40.0K | $3.61 | −$144.4K | −4.2%906.6K after | 10b5-1 |
| Apr 8, 2026 (view filing) | Apr 7 | 1 day | Gibson ChristopherDirector | SSaleClass A Common Stock | −40.0K | $3.10 | −$124.0K | −4.2%906.6K after | 10b5-1 |
| Mar 25, 2026 (view filing) | Mar 23 | 2 days | Gibson ChristopherDirector | SSaleClass A Common Stock | −40.0K | $3.25 | −$130.0K | −4.2%906.6K after | 10b5-1 |
| Feb 19, 2026 (view filing) | Feb 19 | Same day | Gibson ChristopherDirector | SSaleClass A Common Stock | −40.0K | $3.46 | −$138.4K | −4.2%906.6K after | 10b5-1 |
| Feb 6, 2026 (view filing) | Feb 4 | 2 days | Gibson ChristopherDirector | SSaleClass A Common Stock | −40.0K | $4.12 | −$164.8K | −4.2%913.8K after | 10b5-1 |
| Jan 22, 2026 (view filing) | Jan 20 | 2 days | Gibson ChristopherDirector | SSaleClass A Common Stock | −40.0K | $4.47 | −$178.8K | −4.2%913.8K after | 10b5-1 |
| Jan 7, 2026 (view filing) | Jan 5 | 2 days | Gibson ChristopherDirector | SSaleClass A Common Stock | −40.0K | $4.25 | −$170.0K | −4.1%933.8K after | 10b5-1 |